PTGS2 and cancer: Over-expression of COX-2 has been detected in a number of malignancies including breast cancer, and contributes to carcinogenesis by stimulating cancer cell proliferation, inhibiting apoptosis, increasing invasiveness and modulating inflammation and immunity [8, 9].